BioSig Technologies, Inc. STEX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s operating cash flow?
- BioSig Technologies, Inc. (STEX) reported operating cash flow of -$10.18M in Q1 2026.
- How has BioSig Technologies, Inc.'s operating cash flow changed year-over-year?
- BioSig Technologies, Inc.'s operating cash flow decreased by 812.9% year-over-year, from -$1.12M to -$10.18M.
- What is the long-term trend for BioSig Technologies, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), BioSig Technologies, Inc.'s operating cash flow has grown at a -20.7% compound annual growth rate (CAGR), from -$26.4M to -$10.44M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.